These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. 27 amino acid residues can be deleted from the N-terminus of human lymphotoxin without impairment of its cytotoxic activity. Nishikawa S, Matsuo N, Isaka Y, Uesugi S, Miura K, Ohtsuka E, Takeda K, Konno K, Ikehara M. J Mol Recognit; 1990 Apr; 3(2):94-9. PubMed ID: 2361063 [Abstract] [Full Text] [Related]
29. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Kohno T, Brewer MT, Baker SL, Schwartz PE, King MW, Hale KK, Squires CH, Thompson RC, Vannice JL. Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8331-5. PubMed ID: 2172983 [Abstract] [Full Text] [Related]
30. A 20 amino acid synthetic peptide of a region from the 55 kDa human TNF receptor inhibits cytolytic and binding activities of recombinant human tumour necrosis factor in vitro. Hwang CD, Gatanaga M, Innins EK, Yamamoto RS, Granger GA, Gatanaga T. Proc Biol Sci; 1991 Aug 22; 245(1313):115-9. PubMed ID: 1682934 [Abstract] [Full Text] [Related]
35. Structure-activity studies of human tumour necrosis factors. Van Ostade X, Tavernier J, Fiers W. Protein Eng; 1994 Jan 22; 7(1):5-22. PubMed ID: 8140094 [Abstract] [Full Text] [Related]